Relay Therapeutics, Inc.

NASDAQ:RLAY

Biotechnology

Healthcare
$15.91 +2.63%

+$0.41 today

Market cap
$3.52B
Beta
1.75
P/E (TTM)
-10.5
EPS (TTM)
-$1.52
52W Low $3.03High $17.47

Volume 1.88M

Average 3.70M

Price history

Relay Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+150.95%

Period high

$20.75

Period low

$6.34

Latest

$15.91

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 4, 2026Nov 4, 2026
10-QNov 4, 2026Nov 4, 2026
4Oct 30, 2026Oct 30, 2026
4Oct 30, 2026Oct 30, 2026
4Oct 30, 2026Oct 30, 2026
4Oct 8, 2026Oct 8, 2026
4Oct 8, 2026Oct 8, 2026
4Sep 9, 2026Sep 9, 2026
4Sep 9, 2026Sep 9, 2026
4Sep 9, 2026Sep 9, 2026
4Aug 28, 2026Aug 28, 2026
4Aug 28, 2026Aug 28, 2026
4Aug 18, 2026Aug 18, 2026
4Aug 18, 2026Aug 18, 2026
SC 13G/AAug 14, 2026Aug 14, 2026

Competitors

Who does Relay Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about RLAY's filings, answered from its disclosures.

What is the latest RLAY filing?

The latest filing shown is 10-Q dated Nov 4, 2026.

How many recent filings does RLAY have?

Intrinsic Alpha currently shows 20 recent filings for RLAY.